Evaluation of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma and Ocular Hypertension
Completed · Phase 3 · Has a placebo group
Conditions studied: Ocular Hypertension, Open-angle Glaucoma
In brief
Evaluation of the ocular hypotensive efficacy and safety of Netarsudil (AR-13324) Ophthalmic Solution compared to Timolol Maleate Ophthalmic Solution
Key facts
- Study ID
- NCT02207621
- Run by
- Aerie Pharmaceuticals
- People needed
- 756
- Starts
- 2014-07-01
- Expected to finish
- 2016-03-01
- Last updated by the study team
- 2018-04-06
Who can join
Age: any, up to 99. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Aerie Pharmaceuticals — Bedminster, New Jersey, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.